Mechanisms by which regulatory T (T reg ) cells fail to control inflammation in asthma remain poorly understood. We show that a severe asthma-associated polymorphism in the gene encoding the interleukin (IL)-4 receptor alpha chain (Il4ra R576 ) promotes conversion of induced T reg (iT reg ) cells toward a T helper 17 (T H 17) cell fate. This skewing is mediated by the recruitment by IL-4Ra R576 of the growth-factor-receptor-bound protein 2 (GRB2) adaptor protein, which drives IL-17 expression by activating a pathway that involves extracellular-signal-regulated kinase, IL-6 and the transcription factor STAT3. T reg cell-specific deletion of genes that regulate T H 17 cell differentiation, including Il6ra and RAR-related orphan receptor gamma (Rorc), but not of Il4 or Il13, prevented exacerbated airway inflammation in mice expressing Il4ra R576 (hereafter referred to as Il4ra R576 mice). Furthermore, treatment of Il4ra R576 mice with a neutralizing IL-6-specific antibody prevented iT reg cell reprogramming into T H 17-like cells and protected against severe airway inflammation. These findings identify a previously unknown mechanism for the development of mixed T H 2-T H 17 cell inflammation in genetically prone individuals and point to interventions that stabilize iT reg cells as potentially effective therapeutic strategies. npg
Asthma is characterized by airway hyper-responsiveness (AHR), chronic inflammation and tissue remodeling 1 . Evidence points to reduced frequency and/or suppressive activity of FOXP3 + T reg cells in asthma and atopic conditions [2] [3] [4] . Intense inflammation in experimental allergic asthma, as well as in other conditions such as rheumatoid arthritis and multiple sclerosis, may lessen T reg cell suppression or redirect T reg cells to pro-inflammatory phenotypes [5] [6] [7] [8] [9] ; however, the molecular basis for impaired T reg cell function in asthma and the effect of T reg cell dysfunction on asthma severity remain to be fully elucidated.
The cytokines IL-4 and IL-13, which function via two distinct heterodimeric IL-4 receptor complexes, have a pivotal role in asthma pathogenesis. IL-4, which binds to both the IL-4R type I (composed of the IL-4Rα and the common cytokine receptor γc chains) and type II (composed of the IL-4Rα and IL-13Rα1 chains) directs T H 2 cell differentiation. In contrast, IL-13, which exclusively binds to the IL-4R type II, promotes airway inflammation and remodeling 10 . Increased signaling via IL-4rα and the downstream transcription factor STAT6 exacerbates allergic airway inflammation and promotes food allergy; STAT6 has been shown to involve suppressed differentiation of allergen-specific T reg cells and their re-programming into T H 2 cell-like cells 9, 11 .
Polymorphisms in the gene encoding IL-4Rα are associated with atopy and asthma 12 . In particular, a glutamine (Q)-to-arginine (R) substitution at amino acid residue 576 of human IL-4Rα (IL-4Rα Q576R ) has been linked to asthma exacerbation and severity [13] [14] [15] [16] . The Gln576 residue is conserved in the murine IL-4Rα chain. Its replacement by Arg576 in ll4ra tm2Tch mice (also known as Il4ra R576 mice) resulted in augmented allergic airway inflammation, severe eosinophilic infiltration and increased T H 2 responses 17, 18 . Gln576 lies immediately downstream of a STAT6-binding site at Tyr575, one of three such sites present in IL-4Rα (ref. 19 ), yet no discernable effect of the Arg576 mutation on STAT6 activation has been noted, indicating that Arg576 mobilizes alternative signaling pathways 17, 20 . We show here that the IL-4Rα R576 mutant enables recruitment of the adaptor GRB2 to promote airway inflammation by a mechanism involving IL-4directed iT reg cell differentiation toward the T H 17 cell lineage.
RESULTS
Il4ra R576 T reg cell phenotype in allergic airway inflammation Whereas allergic asthma has classically been associated with a skewed T H 2 cell response, a subgroup of patients with severe disease manifest a mixture of T H 2 and T H 17 cell responses in their airways [21] [22] [23] [24] .
To determine whether the IL-4Rα R576 -encoding mutation elicits T H 17 airway responses in vivo, we used a house dust mite (HDM)induced model of airway inflammation 18 . Il4ra R576 mice, which are homozygous for the Il4ra R576 mutation, showed severe airway inflammation, as compared to control mice that were homozygous for the wild-type (WT) Il4ra Q576 allele. The Il4ra R576 mice had increased inflammatory cell infiltrates and mucus production, accentuated methacholine-induced AHR and robust lung tissue eosinophilia accompanied by neutrophilia, the latter of which was masked in earlier studies by the use of alum as an adjuvant (data not shown) ( Fig. 1a-e) 17 . HDM treatment led to increased frequency and number of T reg cells in lung tissues of WT mice, but this increase was tempered in Il4ra R576 mice (Fig. 1f) . In contrast, HDM-treated Il4ra R576 mice had substantially increased frequencies and numbers of IL-17-, IL-13-and IL-6-expressing CD4 + FOXP3 − conventional T (T conv ) cells and CD4 + FOXP3 + T reg cells, as compared to HDM-treated WT control mice ( Fig. 1g-i) . Expression of IL-17 and IL-6, but not of IL-13, in Il4ra R576 T conv and T reg cells was largely overlapping ( Supplementary  Fig. 1a,b) . Expression of IL-17, IL-13 and IL-5 was increased, whereas expression of interferon (IFN)-γ was decreased, in the bronchoalveolar lavage (BAL) fluid of HDM-treated Il4ra R576 mice as compared to that in the BAL fluid of HDM-treated WT control mice (Supplementary Fig. 1c ). Furthermore, HDM exposure was associated with increased expression of the T H 17-and T H 2-promoting transcription factors ROR-γt and GATA3, respectively, in lung T conv and T reg cells ( Supplementary Fig. 1d-g) . The frequencies and numbers of IL-4-producing T conv and T reg cells in lung tissues of HDM-treated Il4ra R576 mice tended to increase as compared to those in WT controls, whereas the frequencies and numbers of IFN-γ-producing cells were unchanged ( Supplementary Fig. 1h,i) .
Expression of the transcription factor Helios differentiates between natural T reg (nT reg ) cells, which develop in the thymus and are biased toward recognition of self-antigens, and iT reg cells, which arise de novo in the peripheral tissues and are biased toward recognition of foreign antigens 25 . Analysis of the T reg cells in lung tissue revealed decreased numbers of FOXP3 + Helios low T reg cells in HDM-treated Il4ra R576 as compared to those in HDM-treated WT mice, indicating the existence of a reduced iT reg cell population ( Supplementary  Fig. 2a,b) . Expression of IL-17 and the T H 17 cell-associated chemokine receptor CCR6 was largely overlapping and highly enriched in T reg and T conv cells of HDM-treated Il4ra R576 mice, as compared to that in WT mice ( Supplementary Fig. 2c,d) . In Il4ra R576 T reg cells, IL-17 and CCR6 were almost exclusively restricted to the FOXP3 + Helios low iT reg cell population ( Supplementary Fig. 2e,f) 26, 27 .
Il4ra R576 iT reg cells express IL-13, IL-17 and IL-6 Treatment with transforming growth factor (TGF)-β1 together with stimulation of theT cell receptor (TCR) converts naive CD4 + FOXP3 − T cells into FOXP3 + iT reg cells 28 . Given the increased production of IL-17 and IL-13 in lung T reg cells of allergen-exposed Il4ra R576 mice, we examined in vitro-generated Il4ra R576 iT reg cells for aberrant cytokine expression and functional competency in suppressing allergic airway inflammation. We used WT and Il4ra R576 DO11.10 + Rag2 −/− Foxp3 EGFP mice, which express the DO11.10 TCR specific for an ovalbumin (OVA 323-339 ) peptide. These mice normally carry naive CD4 + DO11.10 + Foxp3 − , but not Foxp3 + , T cells by virtue of being on a recombination activation gene 2 (Rag2)-deficient background. They also carry a Foxp3 allele (Foxp3 EGFP ) that enables expression in differentiated iT reg cells of the enhanced green fluorescent protein (EGFP) under control of the germline Foxp3 promoter. Naive WT and Il4ra R576 CD4 + DO10.11 + Rag2 −/− Foxp3 EGFP T cells were purified by cell sorting and differentiated into iT reg cells in culture by stimulation with CD3-and CD28-specific monoclonal antibodies (mAbs) and TGF-β1. Il4ra R576 CD4 + T cells showed decreased conversion to FOXP3 + T reg cells as compared to WT controls, a deficit that was exacerbated by the addition of IL-4 to the cell cultures ( Fig. 2a,b) .
Notably, a sizeable fraction of Il4ra R576 , but not of WT, CD4 + FOXP3 + iT reg cells and CD4 + FOXP3 − T conv cells expressed IL-17, which was further increased by exposure to IL-4 ( Fig. 2c,d) . Anti-CD3 and anti-CD28 stimulation of Il4ra R576 T cells induced elevated expression of IL-13 as compared to that in WT controls, independently of added TGF-β1. IL-13 and IL-17 expression was largely non-overlapping. Addition of IL-4 induced increased IL-17 and IL-13 production in both CD4 + FOXP3 + and CD4 + FOXP3 − populations ( Fig. 2e,f) . In line with the above studies, expression of ROR-γt and GATA3 was upregulated in Il4ra R576 iT reg cells relative to that in WT control cells ( Fig. 2e,f and Supplementary Fig. 3a,b) . IL-6 was co-expressed with IL-17 in Il4ra R576 T reg cells (Fig. 2g,h) ; expression of both cytokines was IL-4 dependent, and IL-17 expression was also IL-6 dependent, consistent with autocrine and paracrine IL-4 production driving IL-6-dependent IL-17 expression ( Fig. 2g,h) . In contrast, IL-13 and IL-4 expression was increased in Il4ra R576 T reg cells in an IL-4-but not IL-6-dependent manner ( Supplementary Fig. 3c-e ). IL-4 plus TGF-β1 treatment induced a modest, equivalent increase in IL-9 expression in WT and Il4ra R576 iT reg cells ( Supplementary Fig. 3f-h) .
The cell surface protein neuropilin 1 (NRP1) is highly expressed on nT reg cells but not on iT reg cells 29, 30 . To determine the effect of IL-4 signaling on Il4ra R576 nT reg cells, splenic NRP1 high WT and Il4ra R576 T reg cells, which are overwhelmingly nT reg cells 29, 30 , were isolated to high purity by cell sorting (Supplementary Fig. 4a ) and examined for their suppressive capacity in an in vitro T cell proliferation assay. IL-4 treatment did not affect the suppressive function of either WT or Il4ra R576 nT reg cells (Supplementary Fig. 4b,c) . Treatment with anti-CD3 and anti-CD28 in the presence of IL-4 induced expression of IL-17 but not IL-13 in a minor population of Il4ra R576 , but not WT, nT reg cells that was on average tenfold less in frequency than that noted for IL-4-treated Il4ra R576 iT reg cells ( Supplementary  Fig. 4d,e ). Also, treatment of naive Il4ra R576 T conv cells with IL-4 failed to induce IL-17 expression in the absence of TGF-β1 ( Supplementary  Fig. 4f,g) . These results indicated that the capacity of Il4ra R576 T reg cells to express IL-17 in response to IL-4 treatment is largely restricted to the iT reg cell population.
Impaired function of Il4ra R576 T reg cells
To assess the suppressive capacities of Il4ra R576 versus WT iT reg cells, we used an adoptive transfer model. iT reg cells were derived from naive splenic CD4 + T cells of WT and Il4ra R576 Thy1.1 + DO10.11 + Rag2 −/− Foxp3 EGFP mice and adoptively transferred to OVA-sensitized Il4ra R576 Thy1.2 + mice, which were then challenged with aerosolized OVA and analyzed ( Supplementary Fig. 5a ). WT iT reg cells almost completely abrogated OVA-induced tissue inflammation, goblet cell hyperplasia, AHR, eosinophilia-neutrophilia and lymphocytosis in the lungs of recipient Il4ra R576 mice. They also suppressed IL-17 and IL-13 expression in the recipient lung T conv and T reg cells. In contrast, Il4ra R576 iT reg cells failed to do so ( Supplementary Fig. 5b-f ). Unlike the transferred WT iT reg cells, up to a third of donor Il4ra R576 iT reg cells lost their EGFP expression to become exiT reg cells that expressed either IL-17 or, less frequently, IL-13, consistent with heightened instability (Supplementary Fig. 5g-j) .
We used CCR6 as a marker of T reg cells that were committed toward the T H 17 cell lineage to examine their functional, epigenetic and transcriptional profiles. CCR6 + Il4ra R576 T reg cells isolated from OVA-sensitized and challenged mice showed decreased methylation of the Foxp3 CNS2 enhancer region, indicative of decreased T reg cell phenotypic stability ( Fig. 3a,b) . They also showed profoundly decreased suppressive function in an in vitro T cell proliferation assay, npg a r t i c l e s nature medicine VOLUME 22 | NUMBER 9 | SEPTEMBER 2016 1 0 1 5
as compared to CCR6 − WT and CCR6 − Il4ra R576 T reg cells ( Fig. 3c ).
Transcriptional profiling revealed increased expression in CCR6 + Il4ra R576 T reg cells of genes associated with a T H 17 cell signature, including Rorc, Ccr6, Il23r, Il17a, Il17f, Il1r1, Nr1d1, Cstl and Ahr ( Fig. 3d and Supplementary Data Set 1) 26, [31] [32] [33] . To determine whether the T H 17 cell-like T reg cells in the lungs of allergen-treated Il4ra R576 mice gave rise to FOXP3 − T H 17 cells, we used a lineagetracing approach in Rosa26 Stop-flox yellow fluorescent protein (YFP) reporter (R26 YFP ) mice that were crossed with Foxp3-directed Cre recombinase (Foxp3 EGFPCre ) mice on a WT or Il4ra R576 background. Il4ra R576 Foxp3 EGFPCre R26 YFP and control Foxp3 EGFPCre R26 YFP mice were either sham or OVA sensitized, and then challenged with aerosolized OVA. CCR6 and cytokine expression was examined in T reg (EGFP + YFP + ), exT reg (EGFP − YFP + ) and CD4 + T conv (EGFP − YFP − ) cells. We found markedly increased frequencies of EGFP − YFP + exT reg cells in the lungs of OVA-sensitized and challenged Il4ra R576 Foxp3 EGFPCre R26 YFP relative to those in the lungs of control Foxp3 EGFPCre R26 YFP mice, indicative of heightened T reg cell instability npg 1 0 1 6 VOLUME 22 | NUMBER 9 | SEPTEMBER 2016 nature medicine ( Fig. 3e) . Furthermore, about half of those exT reg cells expressed IL-17 and CCR6, consistent of their differentiation into T H 17 cells.
In contrast, expression of IL-13 by exT reg cells was modest ( Fig. 3f,g) . Together, IL-17-producing T reg and exT reg cells accounted for 35-40% of the total CD4 + IL-17 + and CD4 + CCR6 + T cells in the lungs of OVAtreated Il4ra R576 Foxp3 EGFPCre R26 YFP mice but less than 3% of the cells in similarly treated WT controls ( Fig. 3h) . These results indicated that Il4ra R576 -driven T reg cell instability and T H 17 cell-like programming in the context of allergic airway inflammation ultimately leads to T reg cell transformation to T H 17 cells.
Recruitment of GRB2 to IL-4R phospho-Tyr575 activates MAPK
We noted that the Arg576 substitution rendered the sequence at phospho-Tyr575 (pY 575 ) (G 574 -pY 575 -R-E-F 578 ) homologous to a previously reported consensus sequence for high-specificity binding of the src homology 2 (SH2) domain of the adaptor protein GRB2 (pY-K/R-N-I/L) 34 . Consistent with this prediction, GRB2 and the GRB2-associated binding protein 2 (GAB2) were detected by immunoblotting in IL-4Rα immunoprecipitates derived from IL-4-treated Il4ra R576 T cells but not WT T cells ( Fig. 4a ). Furthermore, GRB2 was recovered from mouse splenocyte and human PBMC lysates by using biotinylated 15-residue murine and human IL-4Rα peptides containing phosphorylated Tyr575 and Arg576 (pY 575 R 576 ) but not the Gln576 residue (pY 575 Q 576 ) ( Fig. 4b and Supplementary  Fig. 6a ). Both murine and human pY 575 R 576 peptides showed a modest decrease in STAT6 binding as compared to that by pY 575 Q 576 . Together, these data indicated that the Arg576 substitution altered the specificity of pTyr575 toward binding GRB2 versus STAT6.
Receptor-bound GRB2 activates the guanine nucleotide exchange factor son of sevenless, which in turn activates the mitogen-activated protein kinase (MAPK) kinase cascade 35 . Consistent with GRB2 recruitment and activation, IL-4 stimulation of Il4ra R576 splenocytes but not of WT splenocytes increased the phosphorylation of MAPKs, including the c-Raf, MKK3, MKK6, ERK1, ERK2 and p38 MAPKs ( Fig. 4c and Supplementary Fig. 6b,c) . Activation of these kinases was inhibited by a Grb2-specific small interfering RNA (siRNA) but not by a scrambled control siRNA (Fig. 4c ). ERK1 and ERK2, but not p38 MAPK, activation was suppressed by treatment with a c-Raf-specific inhibitor, pointing to two downstream cascades branching out from GRB2, one involving c-Raf-ERK1-ERK2 and the other involving p38 MAPK and its activator MKK3-MKK6 ( Supplementary Fig. 6d ). IL-4-activated Il6 transcription in several cell types, including bone marrow (BM)-derived macrophages (BMDM), splenocytes and purified T cells in a GRB2-ERK1-ERK2-cascade-dependent manner, as evidenced by inhibition of Il6 expression by a Grb2-specific siRNA and by treatment with a MAPK kinase (MEK) inhibitor (which inhibits ERK1 and ERK2 activation), but not by a p38 MAPK inhibitor (Fig. 4d,e and Supplementary Fig. 6e ). IL-4 induced ERK1-and ERK2-dependent phosphorylation of NF-κB p65, known transcriptional activators of Il6, and mobilized p65 and C/EBP-β to the Il6 promoter 36, 37 (Fig. 4f  and Supplementary Fig. 6f ). The activation of NF-κB was inhibited by MEK inhibitor treatment (Supplementary Fig. 6g) .
IL-6-dependent STAT3 activation in Il4ra R576 cells IL-6 skews iT reg cell differentiation toward the T H 17 cell lineage in a STAT3-dependent manner 38, 39 . Consequent to IL-4Rα R576 -mediated IL-6 production, differentiating Il4ra R576 iT reg cells showed increased STAT3 activation as compared to that in WT controls, and this STAT3 activation was IL-4 and IL-6 dependent (Fig. 4g) . Analysis of IL-4induced STAT3 activation in naive Il4ra R576 CD4 + T cells revealed delayed phosphorylation of STAT3 that started at 30 min after stimulation and that progressively increased over time. It was completely abrogated by treatment with an IL-6-specific mAb, indicating that IL-4-induced STAT3 phosphorylation proceeded by IL-4-mediated IL-6 production. In contrast, activation by IL-4 of STAT6, and by IL-6 of STAT3, was indistinguishable between WT and Il4ra R576 T cells (Supplementary Fig. 7a-c) . 4 We next analyzed the role of GRB2-activated MAPK cascades in iT reg cell skewing toward a T H 17 versus T H 2 cell phenotype. Treatment of differentiating Il4ra R576 iT reg cells with the MEK inhibitor or an IL-6-specific mAb, but not with a p38 MAPK inhibitor, rescued the decreased iT reg cell differentiation, decreased IL-6 levels in culture and blocked IL-17 expression in differentiating iT reg cells and in CD4 + T conv cells present in the same co-cultures. In contrast, IL-13 expression was not affected by treatment with the MEK inhibitor or an IL-6specific mAb, (Fig. 4h-j and Supplementary Fig. 6h-j) . Treatment with the p38 MAPK inhibitor blocked IL-13 expression but not IL-17 expression, consistent with the role of p38 in the upregulation of Il13 gene transcription by a GATA3-dependent mechanism 40 , whereas treatment with anti-IL-4 blocked both (Fig. 4i,j and Supplementary  Fig. 6i,j) . Thus the two branches of MAPK signaling downstream of IL-4Rα R576 mediate activation of distinct T H cell cytokine programs.
Whereas T cells express only the type I IL-4R, which responds to IL-4, BMDMs also express the type II receptor, which responds to IL-4 and IL-13. Stimulation of Il4ra R576 BMDMs but not WT BMDMs with IL-4 or IL-13 induced a similar profile of delayed, sustained STAT3 activation. In contrast, STAT3 was similarly activated in IL-6treated WT and Il4ra R576 BMDMs (Supplementary Fig. 7d,e) .
Expression of transcripts encoding the chemokine CCL11, which mediates tissue eosinophil recruitment, is markedly upregulated in the airways of allergen-challenged Il4ra R576 mice 17 . Ccl11 transcripts were greatly increased in IL-4-treated Il4ra R576 BMDMs as compared to those in similarly treated WT BMDMs (Supplementary Fig. 7f ). Ccl11 transcriptional activation by IL-4 and IL-13 is normally mediated by STAT6, whereas that by IL-17 and IL-9 is mediated by STAT3 (refs. [41] [42] [43] . Chromatin immunoprecipitation (ChIP) assays revealed that whereas STAT6 bound equally well to the Ccl11 promoter in npg IL-4-treated WT and Il4ra R576 BMDMs, STAT3 was selectively recruited to the Ccl11 promoter in Il4ra R576 BMDMs in an IL-6dependent manner (Supplementary Fig. 7g ). Knockdown of Stat3 expression by siRNA treatment abrogated the increase in Ccl11 transcription in IL-4-treated Il4ra R576 BMDMs, reducing it to levels similar to those of WT controls (Supplementary Fig. 7h,i) . Thus dual STAT6-STAT3 activation by IL-4Rα R576 may promote tissue eosinophilia by super-inducing Ccl11 transcription.
iT reg cells of humans expressing IL4R R576 produce IL- 17 We examined in vitro iT reg cell differentiation in prospectively recruited healthy and asthmatic subjects who were either WT (IL4R Q576/Q576 ), heterozygous (IL4R Q576/R576 ) or homozygous (IL4R R576/R576 ) for the mutated allele (Fig. 5) . The flow cytometric gating strategy used in these studies is outlined in Figure 5a . In healthy subjects, whose demographics are detailed in Supplementary Table 1 , naive heterozygous and homozygous mutant T conv cells differentiated to iT reg cells at lower frequencies as compared to WT T cells, especially in the presence of IL-4 (Fig. 5b) . The deficit in iT reg conversion was rescued by treatment with an IL-6-specific mAb. The differentiated iT reg cells and CD4 + T conv cells that were present in the same co-cultures produced increased amounts of IL-17, as assessed by flow cytometric analysis and by ELISA, which was further upregulated by IL-4 treatment but abrogated by anti-IL-6 treatment (Fig. 5b,d) . IL-13 expression was significantly increased in the activated T cells of subjects carrying the mutated allele, independently of their ability to differentiate into iT reg cells, mirroring the findings in murine Il4ra R576 T cells (Fig. 5b,d) .
We also examined the differentiation and cytokine expression of iT reg cells in prospectively recruited subjects with asthma as a function of IL4R genotype. The demographics, IL4R genotype and disease severity classification of the subjects with asthma are described in Supplementary Table 2 . Although there were no differences in age npg and sex distribution between asthmatics bearing the WT allele versus those who were heterozygous or homozygous for the mutated allele, the latter subjects showed increased asthma severity, in agreement with previously published reports ( Supplementary Table 2 ) [13] [14] [15] [16] . Heterozygous and homozygous mutant, but not WT, iT reg cells of asthmatics also showed IL-6-dependent decreased differentiation and increased IL-17 production ( Fig. 5c,d) . IL-13 expression was upregulated in activated T conv and in iT reg cells of asthmatics regardless of their genotype, although ELISA assays revealed its increased production by cells carrying the mutated allele ( Fig. 5c,d) . Analysis of peripheral blood mononuclear cells (PBMCs) revealed a modest but significant decrease in circulating total T reg cells in asthmatics who were homozygous for the IL4R R576 allele. This decrease was restricted to the FOXP3 + Helios low (iT reg ) cell population, which also manifested a selective increase in CCR6 expression, echoing the results found in Il4ra R576 mice (Fig. 5e,f and Supplementary Fig. 8) . Notably, the frequency of IL-17-expressing CD4 + T conv and T reg cells was selectively increased in subjects who were either heterozygous or homozygous for IL4R R576 . IL-13 expression was modestly increased in CD4 + T conv and T reg cells from the PBMCs of subjects homozygous for IL4R R576 , consistent with heightened T H 17 and T H 2 responses (Fig. 5g) . These results established that IL-4-driven acquisition by iT reg cells of a T H 17 cell-like phenotype is an attribute that segregates with the IL-4Rα R576 -encoding mutation.
Il4ra R576 T reg cell phenotype change affects airway inflammation
To determine whether the acquisition by lung Il4ra R576 T reg cells of a T H 17 cell-like phenotype contributed to exaggerated airway inflammation, we examined the consequences of a T reg cell-specific deletion of Rorc, which encodes the T H 17 cell-promoting transcription factor ROR-γt, on airway inflammation 44 . The T reg cell-specific deletion was effected by crossing mice expressing a loxP-flanked (floxed) Rorc allele with mice expressing Foxp3 YFPCre , a Cre recombinase under the control of the Foxp3 locus ( Supplementary Fig. 9a,b) . T reg cell-specific deletion of Rorc in Il4ra R576 mice (Il4ra R576 Foxp3 YF PCre Rorc ∆/∆ ) decreased airway inflammation, mucus production and AHR after OVA sensitization and challenge such that they resembled those same responses in WT control mice whose T reg cells were either sufficient or deficient in Rorc (Foxp3 YFPCre and Foxp3 YFPCre Rorc ∆/∆ , respectively) and whose own previously mentioned responses were not significantly different (Fig. 6a-c) . It also led to a sharp decrease in lung tissue neutrophilia, lymphocytosis and, to a lesser extent, eosinophilia. In contrast, total and OVA-specific serum IgE concentrations were marginally decreased ( Fig. 6d,e) . Rorc deletion rescued the decrease in lung tissue T reg cells in OVA-sensitized and challenged Il4ra R576 mice (Supplementary Fig. 9c ). It abolished IL-17 expression and normalized CCR6 expression in Il4ra R576 T reg cells, and normalized IL-17 and CCR6 expression in CD4 + T conv cells. In contrast, IL-13 expression was unaffected in Il4ra R576 Foxp3 YFPCre Rorc ∆/∆ T reg cells and marginally affected in CD4 + T conv cells (Fig. 6f-i and Supplementary Fig. 9d-h) . Almost identical results were obtained after Il4ra R576 T reg cell-specific deletion of Il6ra, which encodes the IL-6Rα chain, consistent with the requirement for IL-4-induced IL-6 production in programming T H 17 cell-like T reg cells ( Supplementary  Fig. 10) . Similarly, treatment with anti-IL-6 suppressed airway inflammation and AHR in HDM-treated Il4ra R576 mice, abrogated airway npg neutrophilia and profoundly inhibited the airway eosinophilia. It normalized lung tissue T reg cell numbers and prevented iT reg cell reprograming into T H 17-like cells, and it inhibited T H 2 and T H 17 cytokine production and the increased IgE response (Supplementary Fig. 11) .
In contrast, treatment with an IL-17-specific mAb was less effective in suppressing HDM-induced airway inflammation in Il4ra R576 mice. It partially decreased tissue inflammation and AHR, normalized airway neutrophilia and inhibited IL-17 production; however, it only marginally decreased airway eosinophilia. It failed to suppress IgE or T H 2 cytokine production or to rescue reduced T reg cell numbers in lung tissues (Supplementary Fig. 12) . Although it inhibited the dysregulated airway eosinophilia and CCL11 production observed in HDM-treated Il4ra R576 mice, treatment with a CCL11-specific mAb did not suppress tissue inflammation, airway neutrophilia, T H 2 and T H 17 cytokine or IgE production, nor did it rescue ineffective T reg cell generation in lung tissues (Supplementary Fig. 13 ).
Unlike the case of Rorc and Il6ra, combined T reg cell-specific deletion of Il4 and Il13 had no significant effect on airway inflammation, AHR or lung tissue neutrophilia in OVA-sensitized and challenged Il4ra R576 mice, despite decreased total eosinophilia and total, and OVA-specific, IgE responses. It failed to rescue the decrease in lung tissue T reg cells in inflamed Il4ra R576 mice. Although T reg cell-specific deletion of Il4 and Il13 completely suppressed IL-13 expression in T reg cells and decreased it in CD4 + T conv cells, it left IL-17 expression unaltered in both cell populations (Supplementary Fig. 14) .
For comparison, we used Il4ra F709 mice, which are homozygous for a Tyr709Phe substitution that inactivates the immunotyrosine inhibitory motif of the IL-4Rα chain and consequently augments STAT6 activation 11 . This mutation, which models polymorphisms that encode human IL-4Rα variants that promote STAT6 activation, results in exaggerated allergic airway inflammation due to dysregulated T H 2 immunity 11, 45, 46 . Il4ra F709 T reg cells undergo T H 2 cell-like reprogramming that has a fundamental role in mediating the exaggerated allergic phenotype 9 . Unlike Il4ra R576 mice, T reg cell-specific deletion of Il4 and Il13 in Il4ra F709 mice normalized their airway inflammation, AHR and tissue eosinophilia, and decreased their total and OVA-specific IgE responses. It reversed T reg cell T H 2 cell-like reprogramming, as evidenced by abolishment of their heightened IL-13 expression, and reduced IL-13 production by CD4 + T conv cells, without affecting the low IL-17 expression in CD4 + T conv and T reg cells (Supplementary Fig. 15 ). Thus, the Il4ra R576 and Il4ra F709 augment airway inflammation by two distinct mechanisms-one that elicits a T H 17 cell-like reprograming of T reg cells and the other that elicits a T H 2 cell-like reprograming of T reg cells.
DISCUSSION
Our studies elucidate a previously unknown mechanism for the development of mixed T H 2 and T H 17 cell responses that are relevant to asthma and other allergic inflammatory diseases. By activating an additional branch of IL-4R signaling that is initiated by the adaptor protein GRB2, a mutant-IL-4Rα-encoding polymorphism that is associated with asthma exacerbations and severity potentiates T H 17 and, to a lesser extent, T H 2 responses. Notably, IL-4-induced GRB2 recruitment mediates MAPK-dependent autocrine IL-6 signaling in T cells, which redirects TGF-β-dependent iT reg cell differentiation toward the T H 17 cell lineage. Deletion of Il6ra or Rorc in T reg cells or treatment with an IL-6-specific mAb protected against the deleterious effects of IL-4Rα R576 on airway inflammation, prevented iT reg cell reprogramming toward the T H 17 lineage and normalized the T H 17 cell response, confirming the centrality of iT reg cell acquisition of a T H 17 cell-like phenotype in mediating disease exacerbation by this polymorphism.
In mouse models, IL-17 induces steroid-resistant airway inflammation and neutrophilic infiltration 27, 47, 48 . However, although an IL-17-specific mAb treatment suppressed lung tissue neutrophilia and neutralized IL-17 in the airways of Il4ra R576 mice, it only partially ameliorated the augmented AHR and tissue inflammation, and it failed to normalize the T reg cell response or suppress T H 17-T H 2 polarization. Thus, the efficacy of interventions such as T reg cellspecific deletion of Rorc or Il6ra, or treatment with anti-IL-6 relates not simply to their suppression of IL-17 production but more fundamentally to their stabilization of the iT reg cell response, resulting in better control of airway inflammation.
Studies on Il4ra R576 and Il4ra F709 mice revealed two distinct modes of pathogenic iT reg cell programming relevant to airway inflammation. Whereas IL-4Rα R576 mediated GRB2-dependent iT reg cell programming toward a T H 17 cell-like phenotype, IL-4Rα F709 mediated STAT6-dependent programming toward a T H 2 cell-like phenotype 9 . T reg cell-specific deletion of Il6ra or Rorc in Il4ra R576 mice and of Il4 and Il13 in Il4ra F709 mice reduced airway inflammation in the respective strain back to levels that were associated with the WT Il4ra allele. Il4ra R576 and Il4ra F709 mice model mixed T H 2-T H 17 and T H 2 cell-high asthma inflammatory mechanisms, or endotypes, respectively [49] [50] [51] . Both models indicate that acquisition of iT reg cells of a T H 17 or a T H 2 cell-like program has a fundamental role in the pathogenicity of the respective allele in airway inflammation. Accordingly, pro-asthmatic IL-4R-encoding polymorphisms may promote distinct asthma endotypes (T H 2 cell-high versus mixed T H 2-T H 17 cell inflammation) by directing iT reg cells differentiation toward the respective T H cell program.
Our results indicate that IL-4-directed and IL-6-dependent subversion of IL4R R576 iT reg cells into T H 17-like cells may have a critical role in the asthma severity associated with this allele. Blocking the IL-4R or IL-6R pathways may prevent the subversion of allergenspecific iT reg cells into T H 2-and/or T H 17-like cells, respectively, and provide personalized therapeutic approaches to tolerance re-establishment in asthma 52, 53 .
METHODS
Methods and any associated references are available in the online version of the paper. Accession codes. Gene Expression Omnibus: RNA-seq data are available under accession number GSE80804.
